Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Laura Rubert"'
Autor:
Vincenza Gragnaniello, Alessandro P. Burlina, Renzo Manara, Chiara Cazzorla, Laura Rubert, Daniela Gueraldi, Ermanno Toniolli, Emilio Quaia, Alberto B. Burlina
Publikováno v:
JIMD Reports, Vol 63, Iss 5, Pp 414-419 (2022)
Abstract Gaucher disease (GD) is a lysosomal disorder characterized by the storage of glucosylceramide in macrophages (“Gaucher cells”), particularly in the spleen, liver, and bone marrow. The most common phenotype, GD type 1, usually presents wi
Externí odkaz:
https://doaj.org/article/559bfebfaf6a49b09caec0f0795cb268
Autor:
Vincenza Gragnaniello, Silvia Carraro, Laura Rubert, Daniela Gueraldi, Chiara Cazzorla, Pamela Massa, Stefania Zanconato, Alberto B. Burlina
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 31, Iss , Pp 100878- (2022)
Mucopolysaccharidosis type II (MPS II) is a multisystemic lysosomal storage disorder caused by deficiency of the iduronate 2-sulfatase enzyme. Currently, enzyme replacement therapy (ERT) with recombinant idursulfase is the main treatment available to
Externí odkaz:
https://doaj.org/article/2de6df5a8c154ab3b258ec1e79885e6c
Autor:
Matteo Paoletti, Anna Pichiecchio, Giovanna Stefania Colafati, Giorgio Conte, Federica Deodato, Serena Gasperini, Francesca Menni, Francesca Furlan, Laura Rubert, Fabio Maria Triulzi, Claudia Cinnante
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
White matter (WM) abnormalities and ventricular enlargement in brain MRI are well-known features in infantile-onset Pompe disease (IOPD) in the era of enzyme replacement therapy (ERT). In this multicentric observational retrospective study, we report
Externí odkaz:
https://doaj.org/article/29bd8cd004034c99adb89be849f766b3
Autor:
Vincenza Gragnaniello, Alessandro P Burlina, Giulia Polo, Antonella Giuliani, Leonardo Salviati, Giovanni Duro, Chiara Cazzorla, Laura Rubert, Evelina Maines, Dominique P Germain, Alberto B Burlina
Publikováno v:
Biomolecules, Vol 11, Iss 7, p 951 (2021)
Fabry disease (FD) is a progressive multisystemic lysosomal storage disease. Early diagnosis by newborn screening (NBS) may allow for timely treatment, thus preventing future irreversible organ damage. We present the results of 5.5 years of NBS for F
Externí odkaz:
https://doaj.org/article/4e819e346de74879a1a19db4c2f75def
Autor:
Vincenza Gragnaniello, Daniela Gueraldi, Laura Rubert, Francesca Manzoni, Chiara Cazzorla, Antonella Giuliani, Giulia Polo, Leonardo Salviati, Alberto Burlina
Publikováno v:
International Journal of Neonatal Screening, Vol 6, Iss 4, p 85 (2020)
Mucopolysaccharidosis type I (MPS I) is a progressive lysosomal storage disease, with neurological and visceral involvement, in which early diagnosis through newborn screening (NBS) and early treatment can improve outcomes. We present our first 5 yea
Externí odkaz:
https://doaj.org/article/de1ed01d3021481d83c94580abbd874c
Autor:
Alberto B. Burlina, Giulia Polo, Laura Rubert, Daniela Gueraldi, Chiara Cazzorla, Giovanni Duro, Leonardo Salviati, Alessandro P. Burlina
Publikováno v:
International Journal of Neonatal Screening, Vol 5, Iss 2, p 24 (2019)
The increasing availability of treatments and the importance of early intervention have stimulated interest in newborn screening for lysosomal storage diseases. Since 2015, 112,446 newborns in North Eastern Italy have been screened for four lysosomal
Externí odkaz:
https://doaj.org/article/f8e8436e80d94bad98d696f444f3754c
Autor:
alberto burlina, Ilaria Bettocchi, Giacomo Biasucci, Andrea Bordugo, Serena Gasperini, Luisa La Spina, Evelina Maines, Concetta Meli, Francesca Menni, Sabrina Paci, Elena Procopio, Alessandro Rossi, Laura Rubert, Marco Spada, Flavia Tubili, Albina Tummolo
Publikováno v:
SSRN Electronic Journal.
Autor:
Chiara Cazzorla, Alberto Burlina, Giulia Polo, Laura Rubert, Francesca Manzoni, Vincenza Gragnaniello, Antonella Giuliani, Leonardo Salviati, Daniela Gueraldi
Publikováno v:
International Journal of Neonatal Screening
Volume 6
Issue 4
International Journal of Neonatal Screening, Vol 6, Iss 85, p 85 (2020)
Volume 6
Issue 4
International Journal of Neonatal Screening, Vol 6, Iss 85, p 85 (2020)
Mucopolysaccharidosis type I (MPS I) is a progressive lysosomal storage disease, with neurological and visceral involvement, in which early diagnosis through newborn screening (NBS) and early treatment can improve outcomes. We present our first 5 yea
Autor:
Giulia Polo, Alessandro P. Burlina, Antonella Giuliani, Chiara Cazzorla, Alessandra Biffi, Antonio Marzollo, Laura Rubert, Leonardo Salviati, Daniela Gueraldi, Alberto Burlina
Publikováno v:
Clinical chemistry and laboratory medicineReferences. 58(12)
Objectives Mucopolysaccharidosis type I (MPS I) was added to our expanded screening panel in 2015. Since then, 127,869 newborns were screened by measuring α-L-iduronidase (IDUA) enzyme activity with liquid chromatography tandem mass spectrometry (LC
Autor:
Emilia Parodi 1, Giovanna Russo 2, Piero Farruggia 3, Lucia D Notarangelo 4, Maria T Giraudo 5, Margherita Nardi 6, Fiorina Giona 7, Paola Giordano 8, Ugo Ramenghi 1, 'AIEOP-ITP Study Group' (Appendix 1), Angelica Barone 9, Gianluca Boscarol 10, Simone Cesaro 11, Francesca Fioredda 12, Saverio Ladogana 13, Maria Licciardello 14, Francesca Rossi, Laura Rubert 16, Marco Spinelli 17, Fabio Tucci 1
Background: The aim of the present study was to assess management strategies for immune thrombocytopenia (ITP) among Italian paediatric haematologists, and to compare these with those of recent international guidelines. Predictors of early remission
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3977::6a5d7035af49fc824d20bdacd25e6d5b
http://hdl.handle.net/11591/452028
http://hdl.handle.net/11591/452028